KindlyMD Announces $500K Share Repurchase Program

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $500,000 worth of the Company's common shares ("Shares"), from time-to-time, as market conditions warrant.

Tim Pickett, Chief Executive Officer, "Our stock buyback program demonstrates our confidence in KindlyMD's current valuation, future growth opportunity and commitment to enhancing shareholder value."